Taye A - Search Results

1

Spironolactone inhibits NADPH oxidase-induced oxidative stress and enhances eNOS in human endothelial cells.

Taye A, Morawietz H. Taye A, et al. Iran J Pharm Res. 2011 Spring;10(2):329-37. Iran J Pharm Res. 2011. PMID: 24250362 Free PMC article.

2

Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose.

Taye A, Saad AH, Kumar AH, Morawietz H. Taye A, et al. Eur J Pharmacol. 2010 Feb 10;627(1-3):42-8. doi: 10.1016/j.ejphar.2009.10.045. Epub 2009 Oct 28. Eur J Pharmacol. 2010. PMID: 19878672

3

Aldosterone augments LOX-1-mediated low-density lipoprotein uptake in human umbilical artery endothelial cells.

Taye A, Sawamura T, Morawietz H. Taye A, et al. Pharmacol Rep. 2010 Mar-Apr;62(2):311-8. doi: 10.1016/s1734-1140(10)70271-1. Pharmacol Rep. 2010. PMID: 20508287 Free article.

4

Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats.

Adel H, Taye A, Khalifa MM. Adel H, et al. Among authors: taye a. Naunyn Schmiedebergs Arch Pharmacol. 2014 Dec;387(12):1187-97. doi: 10.1007/s00210-014-1048-3. Epub 2014 Sep 20. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 25238812

5

Hepatoprotective effect of the selective mineralocorticoid receptor antagonist, eplerenone against carbon tetrachloride-induced liver injury in rats.

Taye A, Abdel-Raheem IT. Taye A, et al. Ann Hepatol. 2012 May-Jun;11(3):384-91. Ann Hepatol. 2012. PMID: 22481458 Free article.

6

Protective effect of hydrogen sulfide against cold restraint stress-induced gastric mucosal injury in rats.

Aboubakr EM, Taye A, El-Moselhy MA, Hassan MK. Aboubakr EM, et al. Among authors: taye a. Arch Pharm Res. 2013 Dec;36(12):1507-15. doi: 10.1007/s12272-013-0194-3. Epub 2013 Jul 1. Arch Pharm Res. 2013. PMID: 23812778

7

Combination therapy with losartan and L-carnitine protects against endothelial dysfunction of streptozotocin-induced diabetic rats.

Sleem M, Taye A, El-Moselhy MA, Mangoura SA. Sleem M, et al. Among authors: taye a. Eur J Pharmacol. 2014 Dec 5;744:10-7. doi: 10.1016/j.ejphar.2014.09.032. Epub 2014 Oct 2. Eur J Pharmacol. 2014. PMID: 25281836

8

Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.

Hofni A, El-Moselhy MA, Taye A, Khalifa MM. Hofni A, et al. Among authors: taye a. Eur J Pharmacol. 2014 Dec 5;744:173-82. doi: 10.1016/j.ejphar.2014.10.021. Epub 2014 Oct 27. Eur J Pharmacol. 2014. PMID: 25446917

9

Erratum to: Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats.

Adel H, Taye A, Khalifa MM. Adel H, et al. Among authors: taye a. Naunyn Schmiedebergs Arch Pharmacol. 2016 May;389(5):553-6. doi: 10.1007/s00210-016-1237-3. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27026403 No abstract available.

10

Heme oxygenase-1 contributes to the protective effect of resveratrol against endothelial dysfunction in STZ-induced diabetes in rats.

Hammad ASA, Ahmed AF, Heeba GH, Taye A. Hammad ASA, et al. Among authors: taye a. Life Sci. 2019 Dec 15;239:117065. doi: 10.1016/j.lfs.2019.117065. Epub 2019 Nov 18. Life Sci. 2019. PMID: 31751579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters